NF-AT-luciferase reporter T cell lines as tools to screen immunosuppressive drugs

Biologicals. 1998 Mar;26(1):1-5. doi: 10.1006/biol.1997.0116.

Abstract

The development of safer analogues of immunosuppressants such as cyclosporin A and FK506 is an important goal for a number of clinical applications ranging from transplantation to the treatment of autoimmune diseases. Here we show the generation and the characterization of Jurkat T cell lines stably transfected with a reporter construct containing the firefly luciferase gene under the control of NF-AT. These lines specifically respond in a cyclosporin A-sensitive manner to T cell antigen receptor-derived signals. Due to the high levels of luciferase activity expression fewer than 1000 cells are required for detection of luciferase. In addition, a simplified luciferase assay allows to reduce both the manipulations and the time required for the assay, making these lines potentially useful models for the automated screening of cyclosporin A and FK506 analogues.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclosporine / pharmacology
  • DNA-Binding Proteins / metabolism*
  • Drug Evaluation, Preclinical / methods
  • Genes, Reporter*
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Jurkat Cells
  • Luciferases / genetics*
  • NFATC Transcription Factors
  • Nuclear Proteins*
  • T-Lymphocytes
  • Tacrolimus / analogs & derivatives
  • Transcription Factors / metabolism*
  • Transfection

Substances

  • DNA-Binding Proteins
  • Immunosuppressive Agents
  • NFATC Transcription Factors
  • Nuclear Proteins
  • Transcription Factors
  • Cyclosporine
  • Luciferases
  • Tacrolimus